These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 25027500)

  • 1. State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology.
    Alépée N; Bahinski A; Daneshian M; De Wever B; Fritsche E; Goldberg A; Hansmann J; Hartung T; Haycock J; Hogberg H; Hoelting L; Kelm JM; Kadereit S; McVey E; Landsiedel R; Leist M; Lübberstedt M; Noor F; Pellevoisin C; Petersohn D; Pfannenbecker U; Reisinger K; Ramirez T; Rothen-Rutishauser B; Schäfer-Korting M; Zeilinger K; Zurich MG
    ALTEX; 2014; 31(4):441-77. PubMed ID: 25027500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue models: a living system on a chip.
    Baker M
    Nature; 2011 Mar; 471(7340):661-5. PubMed ID: 21455183
    [No Abstract]   [Full Text] [Related]  

  • 3. The future of the patient-specific Body-on-a-chip.
    Williamson A; Singh S; Fernekorn U; Schober A
    Lab Chip; 2013 Sep; 13(18):3471-80. PubMed ID: 23685915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systems biology for organotypic cell cultures.
    Grego S; Dougherty ER; Alexander FJ; Auerbach SS; Berridge BR; Bittner ML; Casey W; Cooley PC; Dash A; Ferguson SS; Fennell TR; Hawkins BT; Hickey AJ; Kleensang A; Liebman MNJ; Martin F; Maull EA; Paragas J; Qiao GG; Ramaiahgari S; Sumner SJ; Yoon M
    ALTEX; 2017; 34(2):301-310. PubMed ID: 27846345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementing organ-on-chip in a next-generation risk assessment of chemicals: a review.
    Nitsche KS; Müller I; Malcomber S; Carmichael PL; Bouwmeester H
    Arch Toxicol; 2022 Mar; 96(3):711-741. PubMed ID: 35103818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovative organotypic in vitro models for safety assessment: aligning with regulatory requirements and understanding models of the heart, skin, and liver as paradigms.
    Pridgeon CS; Schlott C; Wong MW; Heringa MB; Heckel T; Leedale J; Launay L; Gryshkova V; Przyborski S; Bearon RN; Wilkinson EL; Ansari T; Greenman J; Hendriks DFG; Gibbs S; Sidaway J; Sison-Young RL; Walker P; Cross MJ; Park BK; Goldring CEP
    Arch Toxicol; 2018 Feb; 92(2):557-569. PubMed ID: 29362863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in microfluidic technologies for cell-to-cell interaction studies.
    Rothbauer M; Zirath H; Ertl P
    Lab Chip; 2018 Jan; 18(2):249-270. PubMed ID: 29143053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D in vitro technology for drug discovery.
    Hosseinkhani H
    Curr Drug Saf; 2012 Feb; 7(1):37-43. PubMed ID: 22663957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Special review series on 3D organotypic culture models: Introduction and historical perspective.
    Hayden PJ; Harbell JW
    In Vitro Cell Dev Biol Anim; 2021 Feb; 57(2):95-103. PubMed ID: 33237402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D cell culture models and organ-on-a-chip: Meet separation science and mass spectrometry.
    Lin A; Sved Skottvoll F; Rayner S; Pedersen-Bjergaard S; Sullivan G; Krauss S; Ray Wilson S; Harrison S
    Electrophoresis; 2020 Jan; 41(1-2):56-64. PubMed ID: 31544246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmentally inspired human 'organs on chips'.
    Ingber DE
    Development; 2018 May; 145(16):. PubMed ID: 29776965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microcavity array (MCA)-based biosensor chip for functional drug screening of 3D tissue models.
    Kloss D; Kurz R; Jahnke HG; Fischer M; Rothermel A; Anderegg U; Simon JC; Robitzki AA
    Biosens Bioelectron; 2008 May; 23(10):1473-80. PubMed ID: 18289841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accessing 3D microtissue metabolism: Lactate and oxygen monitoring in hepatocyte spheroids.
    Weltin A; Hammer S; Noor F; Kaminski Y; Kieninger J; Urban GA
    Biosens Bioelectron; 2017 Jan; 87():941-948. PubMed ID: 27665516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in reconstructing intestinal functionalities in vitro: From two/three dimensional-cell culture platforms to human intestine-on-a-chip.
    Wang L; Wu J; Chen J; Dou W; Zhao Q; Han J; Liu J; Su W; Li A; Liu P; An Z; Xu C; Sun Y
    Talanta; 2021 May; 226():122097. PubMed ID: 33676654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human organotypic bioconstructs from organ-on-chip devices for human-predictive biological insights on drug candidates.
    Cavero I; Guillon JM; Holzgrefe HH
    Expert Opin Drug Saf; 2019 Aug; 18(8):651-677. PubMed ID: 31268355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-industrial applications of organotypic models.
    Kopanska KS; Rimann M
    ALTEX; 2022; 39(1):155-158. PubMed ID: 35034134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of 3D multicellular microfluidic chip for an in vitro skin model.
    Lee S; Jin SP; Kim YK; Sung GY; Chung JH; Sung JH
    Biomed Microdevices; 2017 Jun; 19(2):22. PubMed ID: 28374277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicological evaluation of airborne particulate matter. Are cell culture technologies ready to replace animal testing?
    Silvani S; Figliuzzi M; Remuzzi A
    J Appl Toxicol; 2019 Nov; 39(11):1484-1491. PubMed ID: 31025406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cultivating human tissues and organs over lab-on-a-chip models: Recent progress and applications.
    Bhagat S; Singh S
    Prog Mol Biol Transl Sci; 2022; 187(1):205-240. PubMed ID: 35094775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling chemotherapy-induced peripheral neuropathy using a Nerve-on-a-chip microphysiological system.
    Kramer L; Nguyen HT; Jacobs E; McCoy L; Curley JL; Sharma AD; Moore MJ
    ALTEX; 2020; 37(3):350-364. PubMed ID: 32388569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.